Form 4 for OSCR Oscar Health, Inc.
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001844320-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-08 | 2026-01-06 | OSCR | Schlosser Mario | CTO, Pres of Technology, Dir | C - Cnv Deriv | — | +77.0K | 427.1K | +22% | — |
| DT | 2026-01-08 | 2026-01-06 | OSCR | Schlosser Mario | CTO, Pres of Technology, Dir | S - Sale | $17.01 | -77.0K | 350.2K | -18% | -$1.31M |
| DT | 2026-01-08 | 2026-01-06 | OSCR | Schlosser Mario | CTO, Pres of Technology, Dir | C - Cnv Deriv | $0.00 | -77.0K | 1.46M | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-06 | C | A | 76,962 | — | 427,142 | D | — | — | (F1) The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. (F2) The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. |
| 2 | Common | Class A Common Stock | 2026-01-06 | S | D | 76,962 | $17.01 | 350,180 | D | — | — | (F1) The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 3 | Derivative | Class B Common Stock | 2026-01-06 | C | D | 76,962 | $0.00 | 1,455,331 | D | — · — to — | 76,962 Class A Common Stock | (F1) The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025. (F2) The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. |